CClinicalTrials.gg
WithdrawnNCT02193763Updated Oct 4, 2024

Bedside Ultrasound Assisted Pediatric Lumbar Puncture

An interventional study of Ultrasound assisted lumbar puncture in Infant/ Neonate Lumbar Puncture, sponsored by Wake Forest University Health Sciences. Withdrawn at 1 site in United States. Open to participants aged Up to 12 Months. Per ClinicalTrials.gov, last updated 2024-10-04.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Supportive care

Why this study was withdrawn
PI has relocated to another institution, no other site PI to take over
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
Up to 12 Months
Sex
All
01

Study summary

This is a prospective, randomized study evaluating the efficacy of bedside ultrasound assisted lumbar puncture in pediatric patients

Read the detailed description

Comparison of bedside ultrasound assisted lumbar puncture to traditional anatomical landmark approach in neonates and young infants requiring lumbar puncture

02

Conditions studied

  • Infant/ Neonate Lumbar Puncture

Browse trials for

Keywords

  • pediatric
  • lumbar puncture
  • ultrasonography
  • efficacy
03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.

Browse Wounds and Injuries studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 12 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Any patient 0-12 months old requiring a lumbar puncture in the pediatric emergency department or inpatient pediatric floor is eligible to participate in the study

Exclusion criteria

Exclusion Criteria:

  • previous back surgeries
  • parent/ guardian inability to understand informed consent
  • parent/guardian refusal of informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    90 days and under--Interventional

    Neonates aged 90 days and under randomized to ultrasound assisted lumbar puncture

    Procedure: Ultrasound assisted lumbar puncture

  • No intervention
    90 days and under--control

    Neonates aged 90 days and under randomized to lumbar puncture using the anatomical landmark approach

  • Experimental
    Over 90 days--Interventional

    Neonates aged over 90 days randomized to ultrasound assisted lumbar puncture

    Procedure: Ultrasound assisted lumbar puncture

  • No intervention
    Over 90 days--Control

    Neonates aged over 90 days randomized to lumbar puncture using the anatomical landmark approach

Interventions

  • ProcedureUltrasound assisted lumbar puncture

    An investigator will perform beside ultrasound on the spinal area using a bedside ultrasound device. Attempts will be made to visualize the spinous processes and vertebral bodies in the general lumbarsacral area, as well as the presence of CSF in the thecal space below the conus medullaris, and identify the optimal location to perform the LP. This will be marked with a skin marker (If no CSF or abnormal anatomy is visualized, the LP will be advised to be postponed or cancelled). The treating physician will then proceed with the LP guided by the skin markings.

    Also known as: Sonosite M-Turbo ultrasound device (Bothell, WA) with a L25 linear transducer, or, Zonare Z.One device(Mountain View, CA) with a L10-5 linear array transducer,

06

What researchers measure

Primary outcomes

  1. Traumatic lumbar puncture

    RBC\>10,000/ mm3 on spinal fluid analysis

    Time frame: up to 24 hours

  2. Unsuccessful lumbar puncture

    failure to yield enough fluid for cerebrospinal fluid cell count as indicated by operator report on data collection sheet

    Time frame: average of <1hour

Secondary outcomes

  1. Hospital length of stay

    as reported in the subjects' medical record

    Time frame: average of <7days

Other outcomes

  1. clinical outcome/ hospital course of the patient

    whether there was any adverse effect/ complication due to lumbar puncture based on review of medical record

    Time frame: 30days

  2. number of lumbar puncture attempts

    as recorded on the data collection form

    Time frame: average of <1hour

  3. time to completion of lumbar puncture

    as reported in the data collection form (measured in seconds)

    Time frame: average of <1hour

  4. perception of the clinician on the usefulness of bedside ultrasound if used

    as rated on a 1-5 Likert scale by the operator on the data collection form

    Time frame: up to 24 hours

07

Study locations

1 site
  • Advocate Christ Medical Center
    Oak Lawn, Illinois 60453, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02193763
Lead sponsor
Wake Forest University Health Sciences
Responsible party
Sponsor
First posted
Jul 18, 2014
Start date
Aug 2009
Primary completion
Jun 2024
Completion
Jun 2024
Last update
Oct 4, 2024

Study contacts

Samuel Lam, MD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion